Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1361 Articles

Joel South | Jul 13, 2026 at 8:30 AM EDT

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into…

Drew Wood | Jul 13, 2026 at 6:45 AM EDT

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

A legal career can eventually deliver a six-figure income, but the path is rarely passive. The median annual wage for…

Drew Wood | Jul 13, 2026 at 5:00 AM EDT

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The math on replacing $60,000 of annual income looks simple until you ask a different question. At a 3.5% yield,…

Drew Wood | Jul 12, 2026 at 3:09 PM EDT

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Ten years ago, a buyer of Lowe’s (NYSE:LOW | LOW Price Prediction) could pick up shares near $66 and collect…

Drew Wood | Jul 12, 2026 at 11:24 AM EDT

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

Two retirees can both pull $100,000 from $2 million income portfolios and still land in very different places after tax.…

Drew Wood | Jul 11, 2026 at 12:42 PM EDT

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

A 10% dividend feels like a win because it solves the income problem with less capital. The arithmetic is seductive:…

Drew Wood | Jul 11, 2026 at 11:30 AM EDT

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

A stock screener sorted by current yield misses one of the most powerful income stories in the market. Microsoft (NASDAQ:…

Drew Wood | Jul 11, 2026 at 10:15 AM EDT

The Retirement Budget Most People Build Is Backward

Most retirement budgets start with the wrong question. The instinct is to ask, “What yield do I need so the…

Ian Cooper | Jul 11, 2026 at 8:19 AM EDT

Volatility Isn’t the Risk You Should Fear — These Are

Most investors panic when stocks turn red, but the losses that actually destroy wealth rarely show up on a bad…

Drew Wood | Jul 10, 2026 at 3:00 PM EDT

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

Replacing $7,500 a month with dividends is a math problem before it is anything else. The number you need to…

Drew Wood | Jul 10, 2026 at 12:30 PM EDT

A Dividend Portfolio That Pays For Your Pets

Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around…

David Moadel | Jul 10, 2026 at 12:04 PM EDT

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors…

Vandita Jadeja | Jul 10, 2026 at 11:30 AM EDT

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which…

Danielle Liverance | Jul 10, 2026 at 10:08 AM EDT

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

A dividend cut does not announce itself in advance, but the warning signs appear in the financials long before management…

Drew Wood | Jul 10, 2026 at 9:12 AM EDT

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

A long-term care policy does not just protect against a future care bill. It also creates a premium bill that…

1 … 4 5 6 7 8 … 91

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

5 Words A Dividend Investor Never Wants To Hear, And Three Signs You Are About To Hear Them.

What Would It Take to Permanently Cover Long-Term Care Insurance Premiums?

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Featured Reads

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.